FDA has granted accelerated approval to Zepzelca for metastatic small cell lung cancer
The FDA ( Food and Drug Administration ) has granted accelerated approval to Zepzelca ( Lurbinectedin ) for adult patients with metastatic small cell lung cancer ( SCLC ) with disease progression on o ...
read article